ADC Therapeutics SA (ADCT) bonds
ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.35+0.10 (+8.00%)
Close on Nov 17, 2026Market cap $172.35MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
ADC Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in ADC Therapeutics's 10-Q for the period ended Jun 30, 2026
ADC Therapeutics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| Loan Agreement | $175.00M | $124.74M |
See a number that looks wrong?